Product Information
LASTACAFT ONCE DAILY 0.25% DRP is a brand product labeled by Allergan, Inc., priced at $2.8333 per ML under NDC 00023429105. Its NADAC has been published 163 times since Aug 23, 2023.
FDA first approved this application on Jul 28, 2010.
Strength
2.5 mg/mL
Manufacturer
Allergan, Inc.NDC
00023429105
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
5/20/2026
Active Ingredients
ALCAFTADINEApproval Type
New Drug (NDA)
FDA Application
NDA022134FDA Approved
7/28/2010
On Market Since
12/1/2021
Pharmacological Classes
Price Statistics
The NADAC for LASTACAFT ONCE DAILY 0.25% DRP has been published 163 times since Aug 23, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8333 per ML |
|---|---|
| All-time high | $2.8439 (Jan 14, 2026) |
| All-time low | $2.8192 (Aug 23, 2023) |
| 52-week high | $2.8439 |
| 52-week low | $2.8333 |
| Median price | $2.8369 |
| Average price | $2.8335 |
| Largest weekly change | +0.6% (May 22, 2024) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the alcaftadine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
alcaftadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LASTACAFT ONCE DAILY 0.25% DRP?
The current National Average Drug Acquisition Cost (NADAC) for LASTACAFT ONCE DAILY 0.25% DRP, manufactured by Allergan, Inc., is $2.8333 per ML (NDC 00023429105), effective Sep 30, 2026.
How has the price of LASTACAFT ONCE DAILY 0.25% DRP changed over time?
Over the history we have for it, the NADAC for LASTACAFT ONCE DAILY 0.25% DRP has held within roughly two percent of its current level. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for LASTACAFT ONCE DAILY 0.25% DRP?
Since Aug 23, 2023, the NADAC for LASTACAFT ONCE DAILY 0.25% DRP has ranged from a low of $2.8192 (Aug 23, 2023) to a high of $2.8439 (Jan 14, 2026), with a median of $2.8369 per ML.
Are there cheaper alternatives to LASTACAFT ONCE DAILY 0.25% DRP?
No other NADAC-published product currently shares the active ingredient and strength of LASTACAFT ONCE DAILY 0.25% DRP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LASTACAFT ONCE DAILY 0.25% DRP?
LASTACAFT ONCE DAILY 0.25% DRP (NDC 00023429105) is labeled by Allergan, Inc., and CMS classifies it as a brand product.